Whether Tfh cells serve a similar role of SARS-CoV-2 infection is unclear, as some studies have identified increased cytotoxic Tfh numbers in COVID-19 patients, while others have identified decreased Bcl-6+ Tfh numbers and decreased GC counts in similar patients [133,156]. The gene discussed is BCL6; the disease is COVID-19.